Feds charge Thai woman with smuggling prescription drugs
A woman from Thailand used two websites to sell prescription drugs domestically that can't legally be brought into the United States, according to an affidavit unsealed today in Pittsburgh federal court.
Prosecutors have charged Duangthip Chutivaraporn, 32, with several counts of smuggling and fraud. She was arrested March 2 in eastern Louisiana and is being held in the Western District of Pennsylvania without bond, according to court records. A hearing is scheduled for Wednesday.
Sean Grillo, a special agent for the Food and Drug Administration, says in the affidavit that the Chutivaraporn family in Bangkok operates multiple online pharmacy websites that offer to sell prescription drugs without the need of a prescription.
In particular, Duangthip Chutivaraporn was operating www.edrugnet.com and www.overseas-foreign-pharmacy.com, the affidavit says.
Grillo, undercover, met with Chutivaraporn and two others on March 31 to discuss buying drugs wholesale, and Grillo subsequently used another identity to make a retail purchase of illegal generic versions of Abilify and Viagra and an Asia-only version of Zyprexa, the affidavit says.
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.